Similar Articles
151 Intratumoural microorganism can affect the progression of hepatocellular carcinoma
152 Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma
153 Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy
154 Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages
155 Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report
156 Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model
157 Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in patients with hepatocellular carcinoma and portal vein tumor thrombus
158 Combined transarterial chemoembolization and tislelizumab for patients with unresectable hepatocellular carcinoma
159 Timing of antiviral therapy in patients with hepatitis B virus related hepatocellular carcinoma undergoing hepatectomy
160 Calculus bovis in hepatocellular carcinoma: Tumor molecular basis, Wnt/β-catenin pathway role, and protective mechanism
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA